🔵 Low ImpactRegulation
Onesource Specialty Pharma files regulatory update under SEBI norms
Onesource Specialty Pharma files regulatory disclosure under SEBI LODR. This is a routine update as per Regulation 30, indicating compliance with listing obligations. No financial or operational impact evident from the filing. Investors await further details if any material developments follow.
📊 STOCKS: ONESOURCE | 🏢 SECTOR: Pharma | #LOWIMPACT #regulatory
#regulatory#filing#disclosure
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →